Original Article

CME Article: Rise in Neonatal Abstinence Syndrome Rate Is Associated with Increase in Buprenorphine Prescription Numbers

Objectives: Southern Appalachia is a region of the United States that is disproportionately affected by the opioid epidemic and by increasing rates of neonatal abstinence syndrome (NAS). NAS rates increased approximately 400% between 1999 and 2012. Buprenorphine prescriptions written to treat opioid use disorder also increased dramatically. The present study…

Posted in: buprenorphine 8 medication-assisted therapy 3 neonatal abstinence syndrome 7 pregnancy 49

Original Article

Changes in For-Profit Medication-Assisted Therapy Clinics in an Appalachian City

Objectives: This study is a follow-up to previous research regarding buprenorphine medication-assisted therapy (MAT) in Johnson City, Tennessee. For-profit MAT clinics were surveyed to determine changes in tapering practice patterns and insurance coverage during the last 3 years. Methods: Johnson City for-profit MAT clinics; also called office based opioid treatment…

Posted in: buprenorphine 8 medication-assisted therapy 3 pregnancy 49

Original Article

Prevention of Neonatal Abstinence Syndrome in an Outpatient Prenatal Buprenorphine Tapering Program

Objectives: Many addicted pregnant patients receiving buprenorphine medication-assisted therapy (MAT) wish to discontinue this medication while pregnant. This study was undertaken to determine whether outpatient detoxification from buprenorphine during pregnancy is safe and effective when confirmed with postdetoxification urine drug screens (UDSs). Methods: This case series reports the maternal and…

Posted in: medication-assisted therapy 3 neonatal abstinence syndrome 7 pregnancy 49
SMA Menu